Daniel Menold, Vice President, Finance at CymaBay Therapeutics, Inc. (CBAY), sold 41,890 shares at $12.35 ($517K) on 2023-08-09, disclosed to the SEC on 2023-08-11.
Scheduled sale ($517k) by Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.35 | 20,945 | $259K | 50.0% |
| 2 | $12.35 | 20,945 | $259K | 50.0% |
| Total | $12.35 avg | 41,890 | $517K | 100% |
| Filing → |
| CBAY | SELL | 2018-08-31 | $65K | — | Filing → |